发明名称 |
Oligonucleotide-containing pharmacological compositions and their use |
摘要 |
The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals. |
申请公布号 |
US8916529(B2) |
申请公布日期 |
2014.12.23 |
申请号 |
US200711673486 |
申请日期 |
2007.02.09 |
申请人 |
Lakewood-Amedex, Inc. |
发明人 |
Dale Roderic M. K.;Arrow Amy;Thompson Terry |
分类号 |
C12N15/113;A61K38/00 |
主分类号 |
C12N15/113 |
代理机构 |
Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. |
代理人 |
Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. ;Beattie, Esq. Ingrid A. |
主权项 |
1. A composition suitable for administration in a mammal suffering from a pathological disorder or disease comprising two or more modified oligonucleotides, wherein
a.) a first and a second modified oligonucleotide each comprise about seven to seventy-five nucleotides containing seven or more contiguous ribose groups linked by achiral 5′ to 3′ internucleotide phosphate linkages, wherein said ribose groups of said modified oligonucleotides have a 2′ modification, and wherein said 5′ and 3′ ends of said modified oligonucleotides are blocked; b.) said first modified oligonucleotide is complementary to a region of a first gene associated with said pathological disorder or disease and said second modified oligonucleotide is complementary to a region of a second gene associated with said pathological disorder or disease, wherein the sequence of each of said modified oligonucleotides is selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12 and SEQ ID NO: 24; and c.) wherein said first and second modified oligonucleotides are present in a total amount of less than about 7 mg. |
地址 |
Sarasota FL US |